NO20044145L - Assay for anti-INGAP antistoffer - Google Patents

Assay for anti-INGAP antistoffer

Info

Publication number
NO20044145L
NO20044145L NO20044145A NO20044145A NO20044145L NO 20044145 L NO20044145 L NO 20044145L NO 20044145 A NO20044145 A NO 20044145A NO 20044145 A NO20044145 A NO 20044145A NO 20044145 L NO20044145 L NO 20044145L
Authority
NO
Norway
Prior art keywords
ingap
antibodies
assay
ingap antibodies
Prior art date
Application number
NO20044145A
Other languages
English (en)
Norwegian (no)
Inventor
Aaron I Vinik
David A Taylor-Fischwick
Original Assignee
Gmp Endotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gmp Endotherapeutics Inc filed Critical Gmp Endotherapeutics Inc
Publication of NO20044145L publication Critical patent/NO20044145L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4733Acute pancreatitis-associated protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/474Pancreatic thread protein; Reg protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20044145A 2002-03-01 2004-09-30 Assay for anti-INGAP antistoffer NO20044145L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36104002P 2002-03-01 2002-03-01
PCT/US2003/006221 WO2003074549A2 (fr) 2002-03-01 2003-02-28 Test d'anticorps anti-ingap

Publications (1)

Publication Number Publication Date
NO20044145L true NO20044145L (no) 2004-11-30

Family

ID=27789061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044145A NO20044145L (no) 2002-03-01 2004-09-30 Assay for anti-INGAP antistoffer

Country Status (17)

Country Link
US (2) US7166439B2 (fr)
EP (1) EP1478923A4 (fr)
JP (1) JP2005519276A (fr)
KR (1) KR20040105738A (fr)
CN (1) CN1639572A (fr)
AU (1) AU2003216469A1 (fr)
BR (1) BR0308095A (fr)
CA (1) CA2476979A1 (fr)
CO (1) CO5611199A2 (fr)
IL (1) IL163580A0 (fr)
MA (1) MA27184A1 (fr)
MX (1) MXPA04008430A (fr)
NO (1) NO20044145L (fr)
PL (1) PL373569A1 (fr)
RU (1) RU2004129314A (fr)
WO (1) WO2003074549A2 (fr)
ZA (1) ZA200406877B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090142338A1 (en) * 2005-03-04 2009-06-04 Curedm, Inc. Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions
EP1858545A2 (fr) * 2005-03-04 2007-11-28 Curedm Inc. Methodes et compositions pharmaceutiques pour traiter des diabetes sucres de type 1 et d'autres troubles
EP1883417A2 (fr) 2005-05-25 2008-02-06 Curedm Inc. Peptides, derives et analogues associes, et leurs methodes d'utilisation
US8785400B2 (en) * 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
DK2193142T3 (da) * 2007-08-30 2015-04-20 Curedm Group Holdings Llc Præparater og fremgangsmåder til anvendelse af pro-øcellepeptider og analoger dertil
US20110082080A1 (en) * 2007-10-12 2011-04-07 Curedm Group Holdings, Llc Compositions and methods of using the human proislet peptide receptor
US20090288960A1 (en) * 2008-02-12 2009-11-26 Robert Rubin Rapid Detection of Anti-Chromatin Autoantibodies in Human Serum using a Portable Electrochemical Biosensor
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100883A1 (fr) * 1991-11-25 1993-05-26 Dade International Inc. Dosage immunologique a l'aide de peptides synthetiques du htlv-ii
CA2213610C (fr) * 1995-02-22 2013-12-03 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Proteine ingap impliquee dans la neogenese des ilots pancreatiques
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
KR20000052972A (ko) * 1996-10-31 2000-08-25 윌리암 로엘프 드 보에르 유전성의 방사선경화 코팅 조성물 및 상기 코팅재로 피복된 금속 전도체
US6986994B2 (en) * 2001-01-09 2006-01-17 Gmp Endotherapeutics, Inc. INGAP displacement assays

Also Published As

Publication number Publication date
US20070184504A1 (en) 2007-08-09
CO5611199A2 (es) 2006-02-28
MXPA04008430A (es) 2004-11-26
US7166439B2 (en) 2007-01-23
MA27184A1 (fr) 2005-01-03
CA2476979A1 (fr) 2003-09-12
US20030166031A1 (en) 2003-09-04
CN1639572A (zh) 2005-07-13
WO2003074549A2 (fr) 2003-09-12
IL163580A0 (en) 2005-12-18
JP2005519276A (ja) 2005-06-30
EP1478923A2 (fr) 2004-11-24
AU2003216469A1 (en) 2003-09-16
WO2003074549A3 (fr) 2003-12-18
KR20040105738A (ko) 2004-12-16
ZA200406877B (en) 2005-04-08
RU2004129314A (ru) 2005-04-20
PL373569A1 (en) 2005-09-05
BR0308095A (pt) 2006-01-17
EP1478923A4 (fr) 2005-09-21

Similar Documents

Publication Publication Date Title
NO20044347L (no) Anti-alfavbeta6-antistoff
EP1616881A4 (fr) Anticorps anti-mpl
DK1599504T3 (da) Modificeret antistof
EP1482307A4 (fr) Biodetecteur
EP1499352A4 (fr) Anticorps anti-interleukine-9 recombinants
NO20071430L (no) Anti-OX4OL antistoffer
DE602004009744D1 (de) Reagenzbehälter
DK1501856T3 (da) Anti-HER2 antistofvarianter
DE602004022855D1 (de) Interleukin-10-antikörper
EP1396500A4 (fr) Anticorps anti-trail-r
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
EP1288654A4 (fr) Biodetecteur
EP1318396A4 (fr) Biocapteur
EP1308720A4 (fr) Biocapteur
EP1398626A4 (fr) Biocapteur
EP1445605A4 (fr) Biocapteur
EP1353169A4 (fr) Biocapteur
ATE465180T1 (de) Therapeutische anti-igfr1-antikörper- kombinationen
EP1693385A4 (fr) Anticorps anti-cd47 humanise
EP1281955A4 (fr) Biodetecteur
DK1653844T3 (da) Prionspecifikke peptidreagenser
EP1452856A4 (fr) Biocapteur
DE10390346D2 (de) Mikrofluidik-System
EE200300569A (et) CD44v6-spetsiifilised antikehad
DK1164375T3 (da) Assay til antitransglutaminaseantistoffer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application